- Home
- ODP vs KURA Comparison
ODP vs KURA Comparison
Compare ODP & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODP
- KURA
- Stock Information
- Founded
- ODP 1986
- KURA 2014
- Country
- ODP United States
- KURA United States
- Employees
- ODP N/A
- KURA N/A
- Industry
- ODP Other Specialty Stores
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ODP Consumer Discretionary
- KURA Health Care
- Exchange
- ODP Nasdaq
- KURA Nasdaq
- Market Cap
- ODP 611.3M
- KURA 713.5M
- IPO Year
- ODP N/A
- KURA N/A
- Fundamental
- Price
- ODP $21.89
- KURA $8.37
- Analyst Decision
- ODP Hold
- KURA Buy
- Analyst Count
- ODP 1
- KURA 14
- Target Price
- ODP $19.00
- KURA $24.45
- AVG Volume (30 Days)
- ODP 417.8K
- KURA 1.7M
- Earning Date
- ODP 11-05-2025
- KURA 11-06-2025
- Dividend Yield
- ODP N/A
- KURA N/A
- EPS Growth
- ODP N/A
- KURA N/A
- EPS
- ODP 0.84
- KURA N/A
- Revenue
- ODP $6,690,000,000.00
- KURA $83,279,000.00
- Revenue This Year
- ODP N/A
- KURA $60.25
- Revenue Next Year
- ODP N/A
- KURA $155.10
- P/E Ratio
- ODP $13.29
- KURA N/A
- Revenue Growth
- ODP N/A
- KURA N/A
- 52 Week Low
- ODP $11.85
- KURA $5.41
- 52 Week High
- ODP $32.21
- KURA $21.40
- Technical
- Relative Strength Index (RSI)
- ODP 58.41
- KURA 59.66
- Support Level
- ODP $20.05
- KURA $8.08
- Resistance Level
- ODP $22.61
- KURA $8.58
- Average True Range (ATR)
- ODP 0.92
- KURA 0.50
- MACD
- ODP -0.01
- KURA -0.04
- Stochastic Oscillator
- ODP 77.67
- KURA 57.60
About ODP The ODP Corporation
The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on international operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue stems from the Veyer division.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.